Fantastic presentation SSAT by City of Hope Surgical Oncology fellow and incoming UW Department of Surgery Veterans Affairs HPB surgeon, Kevin Labadie, discussing the safety and oncologic efficacy of concurrent hepatectomy with proctectomy

Grateful to have @thomasctsai from Brigham and Women’s Department of Surgery as the keynote speaker for the SSAT Resident and Fellows Education conference discuss his work as a senior member of the White House COVID-19 response task force and plans for the new American College of Surgeons Health Policy Fellowship

Incredible session on managing intraop complications SSAT. Great paradigm from Mark Soliman, MD, MBA AdventHealth for differentiating the experienced surgeon (one who’s done many many cases) vs the expert surgeon (one who’s reflected and improved over time)

Very proud of our Loma Linda U. Health Society of Surgical Oncology fellow Anup Parikh, MD representing us SSAT Digestive Disease Week with a review on the national ☢️ practice for pancreas cancer

⭐️CASSANDRA phase 3 trial of PAXG vs mFFX in R/BR #PDAC ➡️ 3 yr EFS 31% vs 13%; OS immature ➡️phase2 initially then renamed phase3 ➡️somehow no diff in AEs! ➡️2 consecutive ⬆️ca19.9 =event ? Molecular diff in arms -exciting study- warrants further ix ASCO OncoAlert #ASCO25

🚨PANOVA-3🚨 Locally advanced PDAC 🔍 Gem + nab-Paclitaxel +/- Tumor Treating Fields (TTF)⚡️ 🔥TTF Demonstrates: ✅⬆️OS ✅⬆️Distant-Met Free Survival ✅⬆️Pain-Free Survival ✅⬆️QoL 🧐A new SoC option for patients with LAPC. While no improvement in local control seem, perhaps

🚨CASSANDRA🚨 Resectable or BR PDAC 🔍 Neoadjuvant PAXG vs mFOLFIRINOX 🔥PAXG Demonstrates: ✅⬆️EFS ✅⬆️Path response ✅Suggestion of ⬆️OS Has PAXG supplanted FOLFIRINOX as the preferred neoadjuvant systemic tx for localized PDAC?? #ASCO25

🔥❓Is Pre-op Chemoradiation the new SoC for locally advanced gallbladder cancer❓🔥 🚨POLCA-GB🚨 T3-4 or N+ GB cancer 🔍Gem-Cis +- CRT CRT Demonstrated: ✅⬆️OS, at median and with substantial separation at tail of curve (read: dcurability) ✅⬆️PFS ✅⬆️Objective response ✅No

🔥POLCAGB Ph 3 neoadjuvant chemo vs neoadjuvant chemorads + chemo in locally adv GBC ➡️ closed at interim due to poor accrual 124 pts randomised ➡️ORR 74% vs 36% ➡️mOS 22mths vs 10ths Imp data - rads has a role! Nb 20% her2 amp in GBC- needs explored #ASCO25 ASCO OncoAlert

#ASCO25 What does >10 MET-hrs/week actually look like and how can we break it down for patients? That was the CHALLENGE trial target —and it delivered a DFS HR of 0.72. But this isn’t just a number. It’s a prescription. 💡 1 MET = resting energy 10 MET-hrs/week = 150–300 min of

TEDOPAM - maintenance randomised phase 2 vaccine trial #PDAC Induction mFFX- Folfiri vs Folfiri+ OSE2101 (TAAs) ➡️106 pts ➡️met primary endpoint of 12mth OS>50%; ➡️But control arm mOS 17 vs vaccine arm 15mths ➡️highlights benefit maintenance approaches ASCO OncoAlert #ASCO25

🔥NeoPancOne🇨🇦 ➡️mFFX in resectable PDAC ➡️exploring GATA6&subtypes ➡️mEFS &OS 16.3 &34.2mths ➡️1yr EFS 90% in GATA6 hi vs 50% lo ➡️1yr OS classical 95% vs.57% basal-like ⭐️Time to subtype upfront in all PDAC recognising plasticity OncoAlert #ASCO25 Ontario Institute for Cancer Research (OICR) Princess Margaret Cancer Centre

Shocking data 🤯 Effect size is huge, way larger than expected Urgent to seek reproduction/validation of the finding in further studies, given the potential implications on clinical practice and clinical trials (across oncology fields)

Join us on June 17th 8pm CST for the next #SAASSips for medical students: How to Excel on Away Rotations Moderated by Gopika SenthilKumar, PhD with Drs. Deepa Magge, Jed Calata, Priyanka V. Chugh MD, MS, and David Su Register here: forms.gle/niAQjjDxxpzwax…

Congratulations Areeba Saif, MD! Looking forward to the amazing things you will do Loma Linda University Surgical Oncology! 💪

🩸Iron Deficiency for the Practicing Oncologist JCO Oncology Practice ✅A very useful excellent review 👉ascopubs.org/doi/pdf/10.120… ASCO #cancer #oncology #MedX OncoAlert Top Biomedical Science Top Science

For the past 10 years, we have had the great privilege to partner with SocAsianAcadSurg. As this terrific organization transitions to AmJSurgery, we wish them continued growth, success, and impact. Keep up the amazing work, SocAsianAcadSurg! It has been an honor working with you.

Join the SSAT Resident and Fellows Education Committee on Tuesday, July 15, 2025 for a webinar on Preparing for the ABS General Surgery Boards. This session will cover expert advice to help residents and fellows feel confident for exam day. Register now: ow.ly/BeVp50Wn2Km

Peter J. Allen, MD, has been named as the next chair of the Duke Department of Surgery. medschool.duke.edu/news/peter-all…

Congrats to Prakash Pandalai MD FACS on receiving the 2025 SUS Leadership Agility Program Award!